Otonomy General and Administrative Expenses 2011-2026 | OTIC

General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.

What these expenses include

Salaries of administrative staff (executives, HR, accountants, legal personnel)
Office rent and utilities
Office equipment and IT infrastructure
Professional services (auditors, lawyers, consultants)
Insurance
General administrative travel and representation expenses

What the metric indicates

Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure
Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit
Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry
Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines

Annual General and Administrative Expenses Otonomy

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
14.7 M	14.6 M	11.7 M	20 M	46.8 M	49.8 M	23.2 M	7.84 M	3.51 M	2.41 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
49.8 M	2.41 M	19.5 M

Quarterly General and Administrative Expenses Otonomy

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	3.43 M	-	3.75 M	-	3.5 M	3.67 M	4.04 M	-	3.36 M	3.68 M	3.84 M	-	1.9 M	2.88 M	3.28 M	-	4.65 M	5.62 M	6.16 M	-	10.5 M	10.7 M	14.1 M	-	11.9 M	12.8 M	13 M	-	6.49 M	5.35 M	3.5 M	-	2.04 M	1.56 M	1.56 M	-	807 K	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
14.1 M	807 K	5.49 M

General and Administrative Expenses of other stocks in the Biotechnology industry

Issuer	General and Administrative Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	78.3 M	-	2.43 %	$ 254 M	Germany
AbCellera Biologics ABCL	83.2 M	$ 3.44	-4.32 %	$ 1.03 B	Canada
Acorda Therapeutics ACOR	89.7 M	-	-24.86 %	$ 820 K	USA
I-Mab IMAB	900 M	-	-	$ 866 M	China
Acer Therapeutics ACER	12.7 M	-	2.71 %	$ 14 M	USA
Alexion Pharmaceuticals, Inc. ALXN	1.4 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	7.15 M	-	-13.47 %	$ 169 M	France
ADMA Biologics ADMA	91.6 M	$ 15.36	-2.17 %	$ 3.66 B	USA
Cellectis S.A. CLLS	37.9 M	$ 3.53	-3.54 %	$ 116 M	France
AgeX Therapeutics AGE	9.33 M	-	-10.17 %	$ 12.2 K	USA
Apellis Pharmaceuticals APLS	550 M	$ 20.28	0.65 %	$ 2.56 B	USA
Aeglea BioTherapeutics AGLE	47.9 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	17 M	-	-	$ 26.5 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	4.66 M	-	-1.52 %	$ 24.7 M	USA
Akero Therapeutics AKRO	37.9 M	-	-	$ 3.67 B	USA
Midatech Pharma plc MTP	4.95 M	-	-18.52 %	$ 27.3 M	Britain
Akouos AKUS	22.2 M	-	0.23 %	$ 488 M	USA
Alpine Immune Sciences ALPN	18 M	-	-	$ 2.17 B	USA
Nymox Pharmaceutical Corporation NYMX	5.85 M	-	-19.68 %	$ 18.4 M	Canada
AlloVir ALVR	42.9 M	-	4.14 %	$ 49.1 M	USA
Aptorum Group Limited APM	5.41 M	$ 0.79	-1.15 %	$ 4.31 M	China
Autolus Therapeutics plc AUTL	46.7 M	$ 1.51	1.35 %	$ 385 M	Britain
China SXT Pharmaceuticals SXTC	380 K	$ 2.01	-1.36 %	$ 2.86 M	China
Galmed Pharmaceuticals Ltd. GLMD	5.66 M	$ 0.67	7.08 %	$ 624 K	Israel
Adverum Biotechnologies ADVM	63.1 M	-	-	$ 86.2 M	USA
Ampio Pharmaceuticals AMPE	7.08 M	-	-11.43 %	$ 502 K	USA
Институт стволовых клеток человека ISKJ	25.8 M	-	-	-	Russia
Anika Therapeutics ANIK	95.8 M	$ 14.05	-1.44 %	$ 206 M	USA
ANI Pharmaceuticals ANIP	250 M	$ 74.36	-1.64 %	$ 1.44 B	USA
Applied Therapeutics APLT	20.6 M	-	-	$ 8.42 M	USA
Aravive ARAV	13 M	-	-13.39 %	$ 1.45 M	USA
ARCA biopharma ABIO	13.1 M	-	1052.0 %	$ 415 M	USA
Athersys ATHX	20.1 M	-	3.77 %	$ 22.4 M	USA
AVEO Pharmaceuticals AVEO	60.8 M	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	63.3 M	$ 162.43	0.6 %	$ 8.08 B	USA
BioCryst Pharmaceuticals BCRX	266 M	$ 8.49	-0.18 %	$ 1.75 B	USA
BridgeBio Pharma BBIO	531 M	$ 65.66	-0.78 %	$ 12.6 B	USA
Acasti Pharma ACST	7.17 M	-	4.01 %	$ 150 M	Canada
Brainstorm Cell Therapeutics BCLI	7.04 M	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	2.08 B	-	0.49 %	$ 251 B	Cayman-islands
Bellerophon Therapeutics BLPH	6.02 M	-	-74.18 %	$ 955 K	USA
Bellicum Pharmaceuticals BLCM	5.72 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	95.1 M	-	-7.31 %	$ 87 M	USA
CureVac N.V. CVAC	100 M	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	5.92 M	-	5.93 %	$ 314 M	Canada
BioLineRx Ltd. BLRX	4.31 M	$ 2.69	-0.74 %	$ 908 M	Israel
BioMarin Pharmaceutical BMRN	1.15 B	$ 61.3	1.21 %	$ 11.8 B	USA
Burford Capital Limited BUR	99.3 M	$ 7.79	-5.75 %	$ 1.28 B	Britain
CymaBay Therapeutics CBAY	52 M	-	-	$ 3.45 B	USA